Global Contrast Injectors Market Driven by Increasing Chronic DiseasesBy HospiMedica International staff writers[10 Jul 2018]  |
|
| The global contrast injectors market is expected to grow at a CAGR of 5.07% over the forecast period 2018-2022, driven primarily by increasing chronic diseases. In recent years, there has been a significant increase in the demand for medical devices such as contrast injectors for treating such chronic illness arising from the growing incidence of cardiovascular diseases as a result of obesity and increase in blood pressure. These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company. A key trend in the market is the growing demand for automated contrast injectors. A number of technological advances are taking place in contrast media injector systems such as the development of automated contrast injectors, dual head, syringe-less and triple head contrast injectors, and integration of the device with the patients' database. Increasing awareness of information technology in the healthcare sector is resulting in vendors in the contrast injectors market focusing on integrating these contrast media injectors with IT systems including hospital information system (HIS), and picture archiving and communication systems (PACS). However, the high cost of contrast media injectors poses a key challenge to market growth. Related Links: Research and Markets |
|